Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd‐DTPA and USPIO‐enhanced imaging

High grade and metastatic brain tumours exhibit considerable spatial variations in proliferation, angiogenesis, invasion, necrosis and oedema. Vascular heterogeneity arising from vascular co‐option in regions of invasive growth (in which the blood–brain barrier remains intact) and neoangiogenesis is a major challenge faced in the assessment of brain tumours by conventional MRI.

[1]  Gary Box,et al.  Exploring the biomechanical properties of brain malignancies and their pathologic determinants in vivo with magnetic resonance elastography. , 2015, Cancer research.

[2]  L. Nabors,et al.  High‐resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI , 2009, Magnetic resonance in medicine.

[3]  C. Segebarth,et al.  Vessel size index measurements in a rat model of glioma: comparison of the dynamic (Gd) and steady‐state (iron‐oxide) susceptibility contrast MRI approaches , 2012, NMR in biomedicine.

[4]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.

[5]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. , 2013, Neuro-oncology.

[6]  Nicolas Pannetier,et al.  Imaging the microvessel caliber and density: Principles and applications of microvascular MRI , 2015, Magnetic resonance in medicine.

[7]  J. Rees.  Advances in magnetic resonance imaging of brain tumours , 2003, Current opinion in neurology.

[8]  Emmanuel L Barbier,et al.  Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media. , 2010, Radiology.

[9]  Daniele Marin,et al.  Emerging applications for ferumoxytol as a contrast agent in MRI , 2015, Journal of magnetic resonance imaging : JMRI.

[10]  Kristina Potocki,et al.  The differences of water diffusion between brain tissue infiltrated by tumor and peritumoral vasogenic edema. , 2009, Clinical imaging.

[11]  Gary Box,et al.  Bayesian estimation of changes in transverse relaxation rates , 2010, Magnetic resonance in medicine.

[12]  R K Jain,et al.  Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. , 1994, Cancer research.

[13]  Lihua Chen,et al.  The Correlation between Apparent Diffusion Coefficient and Tumor Cellularity in Patients: A Meta-Analysis , 2013, PloS one.

[14]  Simon Walker-Samuel,et al.  Improving apparent diffusion coefficient estimates and elucidating tumor heterogeneity using Bayesian adaptive smoothing , 2011, Magnetic resonance in medicine.

[15]  A. Heerschap,et al.  Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI , 2008, British Journal of Cancer.

[16]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .

[17]  M. Décorps,et al.  Vessel size imaging , 2001, Magnetic resonance in medicine.

[18]  Jae-Hoon Kim,et al.  Multiparametric MR imaging of tumor response to intraarterial chemotherapy in orthotopic xenograft models of human metastatic brain tumor , 2016, Journal of Neuro-Oncology.

[19]  H. Avraham,et al.  Blood-Brain Barrier Integrity and Breast Cancer Metastasis to the Brain , 2010, Pathology research international.

[20]  Catherine A. Sugar,et al.  Finding the Number of Clusters in a Dataset , 2003 .

[21]  Bernd Hamm,et al.  Diffusion‐weighted echo‐planar magnetic resonance imaging for the assessment of tumor cellularity in patients with soft‐tissue sarcomas , 2009, Journal of magnetic resonance imaging : JMRI.

[22]  Samuel Valable,et al.  Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study , 2008, NMR in biomedicine.

[23]  H Lyng,et al.  MRI of human tumor xenografts in vivo: proton relaxation times and extracellular tumor volume. , 1995, Magnetic resonance imaging.

[24]  M. Westphal,et al.  Glioma invasion in the central nervous system. , 1996, Neurosurgery.

[25]  Samuel Valable,et al.  In vivo imaging of vessel diameter, size, and density: A comparative study between MRI and histology , 2013, Magnetic resonance in medicine.

[26]  B A Kall,et al.  Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. , 1987, Journal of neurosurgery.

[27]  Y Usson,et al.  In vivo assessment of tumoral angiogenesis , 2004, Magnetic resonance in medicine.

[28]  M. Rausch,et al.  PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo , 2005, NMR in biomedicine.

[29]  S. Walker-Samuel,et al.  Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas , 2011, The Journal of pathology.

[30]  N. Just.  Histogram analysis of the microvasculature of intracerebral human and murine glioma xenografts , 2011, Magnetic resonance in medicine.

[31]  W. Leenders,et al.  Vessel co-option: how tumors obtain blood supply in the absence of sprouting angiogenesis. , 2002, Endothelium : journal of endothelial cell research.

[32]  S. Walker-Samuel,et al.  Non‐invasive in vivo imaging of vessel calibre in orthotopic prostate tumour xenografts , 2012, International journal of cancer.

[33]  José V. Manjón,et al.  Automated Glioblastoma Segmentation Based on a Multiparametric Structured Unsupervised Classification , 2015, PloS one.

[34]  M. Lerner,et al.  Glioma morphology and tumor‐induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography , 2010, Journal of magnetic resonance imaging : JMRI.

[35]  Martin O. Leach,et al.  Characterizing Heterogeneity within Head and Neck Lesions Using Cluster Analysis of Multi-Parametric MRI Data , 2015, PloS one.

[36]  R. Kerbel,et al.  Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy. , 2006, Cancer research.

[37]  G. Parker,et al.  Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome , 2014, Clinical Cancer Research.

[38]  R. Gillies,et al.  Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results. , 2014, Translational oncology.

[39]  Nelly Gordillo,et al.  State of the art survey on MRI brain tumor segmentation. , 2013, Magnetic resonance imaging.

[40]  Emmanuel L Barbier,et al.  Characterization of Tumor Angiogenesis in Rat Brain Using Iron-Based Vessel Size Index MRI in Combination with Gadolinium-Based Dynamic Contrast-Enhanced MRI , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[41]  Lawrence O. Hall,et al.  Automatic segmentation of non-enhancing brain tumors in magnetic resonance images , 2001, Artif. Intell. Medicine.

[42]  A Heerschap,et al.  Development of luciferase tagged brain tumour models in mice for chemotherapy intervention studies. , 2006, European journal of cancer.

[43]  Luke Macyszyn,et al.  Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques. , 2016, Neuro-oncology.

[44]  Emmanuel Luc Barbier,et al.  Microvascular MRI and Unsupervised Clustering Yields Histology-Resembling Images in Two Rat Models of Glioma , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  A. Balmain,et al.  Guidelines for the welfare and use of animals in cancer research , 2010, British Journal of Cancer.

[46]  A. Twijnstra,et al.  Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma , 2002, Cancer.

[47]  F. Howe,et al.  Susceptibility contrast magnetic resonance imaging determination of fractional tumor blood volume: a noninvasive imaging biomarker of response to the vascular disrupting agent ZD6126. , 2007, International journal of radiation oncology, biology, physics.